KPC Pharmaceuticals Inc Sustainability Reports
KPC Pharmaceuticals, Inc. focuses on the research, development, manufacture, and sales of innovative natural botanical drugs, traditional Chinese medicines, and chemical medicines. Its primary therapeutic product portfolio includes Panax notoginseng, gastrodine, and artemisinin derivatives.
Sector: Manufacturing
Country: China
Exchange: Shanghai Stock Exchange
LEI: 3003007ZALHXKUFMKN96
FIGI: BBG001SGJYR7
2 reports from 2024 to 2025
